14-day Premium Trial Subscription Try For FreeTry Free
Arcturus Therapeutics (ARCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
With the trading day more than halfway over, the broad markets were trading mixed.
Arcturus (ARCT) is likely to discuss the progress of its COVID-19 vaccine candidate on the fourth-quarter earnings call.
SAN DIEGO--(BUSINESS WIRE)---- $ARCT #BioCEO--Arcturus Therapeutics to Present at Upcoming Investor Conferences
Stocks without sturdy fundamentals are toxic for your portfolio. Identifying such bloated stocks accurately and dumping them at the right time can protect your returns.
ARCT peaked and then slumped in recent weeks as investors lost interest in its coronavirus vaccine. Promising platform and advantages suggests this is a worthwhile holding.
With the trading day about half over, the broad markets were pushing higher on Tuesday The S&P 500 and Dow Jones industrial average were both up fractionally, and the Nasdaq posted the largest gain, c

Is Arcturus Therapeutics a Buy?

06:51am, Tuesday, 12'th Jan 2021
Only if its COVID-19 vaccine proves to be at least as effective than those developed by its rivals.
The stock price of Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) increased by over 50% this past week as it went from $46.28 on January 4 morning to $73.58 (as of 10:56 AM ET today). This is why i
The year 2020 can easily be fully attributed to the Nasdaq as the tech-heavy index gained jumped about 44%. However, the index many more reasons to rally this year too.

Why Arcturus Therapeutics Stock Skyrocketed Today

03:19pm, Thursday, 07'th Jan 2021
One Wall Street analyst is very bullish about the biotech's prospects.
Arcturus Therapeutics (NASDAQ: ARCT) shares are trading higher on Thursday after Wells Fargo initiated coverage on the stock with an Overweight rating. Arcturus Therapeutics is an RNA medicines compan
Over halfway through the trading day on Thursday, and the broad markets are making a run into the afternoon.
The biotech's shares jumped by 299% last year, propelled by optimism about its COVID-19 vaccine candidate.
SAN DIEGO--(BUSINESS WIRE)---- $ARCT #BiotechShowcase--Arcturus Therapeutics to Present at Upcoming Investor Conference
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE